经导管主动脉瓣置换术中外科抢救性转开胸的发生率与结局
基于美国国家住院患者样本数据库2017—2021年68 141例经导管主动脉瓣置换术(TAVR)患者,410例(0.6%)发生术后1天内转开胸手术。转开胸发生率从0.50%升至0.68%(Ptrend=.045),转开胸后死亡率从30.0%降至17.9%(Ptrend=.006)。肝病、营养不良和风湿性瓣膜病是转开胸的危险因素。
要点
- TAVR术中转开胸发生率为0.6%,且呈上升趋势。
- 转开胸后死亡率虽下降,但仍高达17.9%。
- 营养不良患者转开胸风险显著升高(OR 3.15)。
核心结论
- 当代TAVR外科转开胸发生率上升,而转开胸后死亡率下降。
- TAVR队列整体风险特征和严重术中心脏损伤有所减少。
研究设计与样本
- 回顾性数据库分析,查询美国国家住院患者样本数据库,纳入2017—2021年18岁及以上以经皮TAVR为主要操作的患者,共68 141例。
- 转开胸定义为TAVR后1天内进行的任何开胸心脏手术。
主要发现
- 410例(0.6%)需要转开胸,转开胸发生率从0.50%升至0.68%(Ptrend=.045)。
- 转开胸后死亡率从30.0%降至17.9%(Ptrend=.006)。
- 转开胸患者更年轻[73.9(12.4)岁 vs 78.5(8.5)岁,P<.001]。
- 转开胸的危险因素包括肝病(OR 1.61,95%CI 1.12-2.31,P=.010)、营养不良(OR 3.15,95%CI 1.91-5.17,P<.001)和风湿性瓣膜病(OR 1.55,95%CI 1.14-2.12,P=.006)。
- 转开胸病例中心脏出血发生率从40.0%降至24.8%(Ptrend=.016),需心包穿刺率从32.0%降至20.5%(Ptrend=.015),复合并发症保持不变。
临床怎么用
- TAVR术中需保持外科转开胸的应急能力,尤其对合并肝病、营养不良或风湿性瓣膜病的患者。
- 尽管转开胸后死亡率下降,但仍需警惕其较高死亡风险,并关注转开胸发生率的上升趋势。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Intraprocedural complications of transcatheter aortic valve replacement (TAVR) continue to necessitate conversion to emergent open cardiac surgery. The need for on-site surgical backup remains debated. This study investigates the current incidence and outcomes of surgical conversions during TAVR in the United States. METHODS: We queried the National Inpatient Sample Database to identify patients aged 18 and older who underwent percutaneous TAVR as the primary procedure between 2017 and 2021. Conversion was defined as any open cardiac surgery performed within 1 day following TAVR. We compared the characteristics and outcomes of patients with and without conversions and analysed trends in conversion incidence and in-hospital mortality, as well as predictors of conversion and post-conversion mortality. RESULTS: Our analysis included 68 141 TAVR patients, of whom 410 (0.6%) required conversion. The incidence of conversion increased from 0.50% to 0.68% (Ptrend = .045). Post-conversion mortality decreased from 30.0% to 17.9% (Ptrend = .006). The patients who underwent conversions were younger [73.9 (12.4) vs 78.5 (8.5), P < .001]. Risk factors for surgical conversion included liver disease [odds ratio (OR) 1.61, 95% confidence interval (CI) 1.12-2.31, P = .010], malnutrition (OR 3.15, 95% CI 1.91-5.17, P < .001), and rheumatic valve disease (OR 1.55, 95% CI 1.14-2.12, P = .006). Among converted cases, the incidence of cardiac bleeding and need for pericardiocentesis decreased from 40.0% to 24.8% (Ptrend = .016) and 32.0% to 20.5% (Ptrend = .015), respectively, while composite complications were constant. CONCLUSIONS: The incidence of surgical conversion increased and post-conversion mortality decreased in the contemporary era. The overall risk profile and severe intraprocedural cardiac injuries have decreased in the TAVR cohort.
引用
- McGrath D, Sun C, Zhu M, et al. Incidence and Outcomes of Surgical Bailout for Transcatheter Aortic Valve Replacement. Eur J Cardiothorac Surg. 2026. PMID: 41346262. doi:10.1093/ejcts/ezaf435
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。